Drugs / spiradoline
spiradoline
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00988949 Background | Nov → Dec 2009 | bipolar depression | Pfizer | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | spiradoline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00988949 ↗ |
| Known as | Espiradolina | ChEMBL registry synonym — accepted as the source's own label CHEMBL118865 ↗ |
| Known as | Spiradoline mesilate | ChEMBL registry synonym — accepted as the source's own label CHEMBL118865 ↗ |
| Known as | SPIRADOLINE MESYLATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL118865 ↗ |
| Known as | U-62066E | ChEMBL registry synonym — accepted as the source's own label CHEMBL118865 ↗ |
| Modality | Small molecule | — CHEMBL118865 ↗ |
| Route | Intramuscular | “to be administered intramuscularly once on the morning of the spiradoline challenge day.” NCT00988949 ↗ |